Cholesterol depletion by methyl-beta-cyclodextrin in breast cancer cell lines increases vesicle release and treatment with pervanadate regulates ADAM10 relocation in microvesicles derived by the Golgi apparatus, while PMA favors ADAM10 transport to the cell membrane [74]. This evidence concerns the gene ADAM10 and breast cancer.